Patent · US Active

Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof

US10329282B2 · kind B2 · utility

5Cited by

1References

45Claims

0Family size

Assignee

BEIJING TIDE PHARMACEUTICAL CO., LTD. · CN

Inventors

Yanping Zhao · Beijing, CN
Hongjun Wang · Ningbo City, CN
Gong Li · Beijing, CN
Yuanyuan Jiang · Beijing, CN
Xiang Li · Beijing, CN
Liying ZHOU · Beijing, CN
Yanan Liu · Beijing, CN

Key dates

Filing date	Sep 29, 2017
Grant date	Jun 25, 2019
Priority date	—
Expiry date	Sep 29, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a Rho-associated protein kinase inhibitor of Formula (I), a pharmaceutical composition comprising the same, a preparation method thereof, and use thereof for the prevention or treatment of a disease mediated by the Rho-associated protein kinase (ROCK).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.